ZHAW Waedenswil: A new Approach in the Fight against Cancer
Biotechnet Switzerland
DOI:
https://doi.org/10.2533/chimia.2018.166Keywords:
Abstract
A happy coincidence brought Dr Markus Rimann from ZHAW Waedenswil together with Dr Andreas Meyer from the start-up FGen and PD Dr Emanuela Felley-Bosco, Molecular Oncologist at Zurich University Hospital, to develop a technology platform for the manufacture and high throughput analysis of single mesothelioma spheroids. Armin Picenoni, former student in Chemistry for the Life Sciences at ZHAW, confirmed everything in writing his Master Thesis on this Innosuisse project.Downloads
Published
2018-03-30
Issue
Section
Columns, Conference Reports
Categories
License
Copyright (c) 2018 Swiss Chemical Society
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
[1]
M. Rimann, Chimia 2018, 72, 166, DOI: 10.2533/chimia.2018.166.